Implementation of Transdx Group for POTS

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 26, 2017

Primary Completion Date

March 1, 2019

Study Completion Date

September 1, 2019

Conditions
DysautonomiaAnxietyDepression
Interventions
BEHAVIORAL

Transdiagnostic Group-Based Treatment

10 week 90-minute weekly therapy sessions including both the adolescent and caregiver. Treatment will consist of psychoeducation about dysautonomia, motivational interviewing techniques to promote readiness for change, support around lifestyle and behavioral changes, core CBT components (e.g., relaxation training, linking thoughts, feelings, and behaviors, minimizing catastrophizing thoughts, cognitive coping, and exposure), and components of ACT aiming to increase cognitive flexibility (e.g., mindfulness, experiential avoidance, values, cognitive defusion, committed action), and relapse prevention and maintenance. Most sessions will involve homework assigned to the adolescent and their parent/legal guardian(s) to encourage practice at home.

Trial Locations (1)

80045

Children's Hospital Colorado, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT03185247 - Implementation of Transdx Group for POTS | Biotech Hunter | Biotech Hunter